Loading...

Fixation Buffer Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL SEK496
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  3. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  4. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  5. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  6. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  7. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  8. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  9. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  10. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  11. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  12. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  13. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  14. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  15. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  16. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  17. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  18. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  19. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  20. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  21. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  22. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  23. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  24. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  25. Chan L, et al. 2022. Cells. 12: . PubMed
  26. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  27. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  28. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  29. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  30. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  31. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  32. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  33. Zander R, et al. 2022. Immunity. 55:475. PubMed
  34. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  35. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  36. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  37. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  38. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  39. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  40. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  41. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  42. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  43. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  44. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  45. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  46. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  47. Wang H, et al. 2023. Nature. 615:339. PubMed
  48. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  49. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  50. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  51. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  52. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  53. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  54. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  55. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  56. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  57. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  58. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  59. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  60. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  61. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  62. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  63. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  64. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  65. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  66. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  67. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  68. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  69. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  70. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  71. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  72. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  73. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  74. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  75. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  76. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  77. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  78. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  79. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  80. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  81. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  82. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  83. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  84. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  85. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  86. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  87. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  88. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  89. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  90. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  91. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  92. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  93. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  94. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  95. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  96. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  97. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  98. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  99. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  100. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  101. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  102. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  103. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  104. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  105. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  106. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  107. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  110. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  111. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  112. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  113. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  114. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  115. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  116. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  117. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  118. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  119. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  120. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  121. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  122. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  123. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  124. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  125. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  126. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  127. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  128. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  129. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  130. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  131. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  132. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  133. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  134. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  135. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  136. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  137. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  138. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  139. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  140. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  141. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  142. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  143. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  144. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  145. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  146. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  147. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  148. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  149. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  150. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  151. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  152. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  153. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  154. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  155. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  156. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  157. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  158. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  159. Ma K, et al. 2022. iScience. 25:104347. PubMed
  160. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  161. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  162. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  163. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  164. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  165. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  166. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  167. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  168. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  169. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  170. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  171. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  172. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  173. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  174. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  175. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  176. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  177. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  178. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  179. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  180. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  181. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  182. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  186. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  187. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  188. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  189. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  190. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  191. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  192. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  193. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  194. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  201. Wang X, et al. 2022. Elife. 11:. PubMed
  202. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  203. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  204. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  205. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  206. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  207. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  208. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  209. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  210. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  211. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  212. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  213. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  214. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  215. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  216. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  217. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  218. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  219. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  220. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  221. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  222. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  223. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  224. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  225. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  226. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  227. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  228. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  229. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  230. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  231. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  232. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  233. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  234. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  235. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  236. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  237. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  238. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  239. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  240. Chan L, et al. 2022. Cells. 12: . PubMed
  241. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  242. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  243. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  244. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  245. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  246. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  247. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  248. Zander R, et al. 2022. Immunity. 55:475. PubMed
  249. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  250. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  251. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  252. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  253. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  254. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  255. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  256. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  257. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  258. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  259. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  260. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  261. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  262. Wang H, et al. 2023. Nature. 615:339. PubMed
  263. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  264. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  265. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  266. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  267. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  268. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  269. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  270. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  271. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  272. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  273. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  274. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  275. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  276. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  277. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  278. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  279. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  280. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  281. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  282. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  283. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  284. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  285. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  286. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  287. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  288. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  289. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  290. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  291. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  292. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  293. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  294. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  295. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  296. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  297. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  298. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  299. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  300. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  301. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  302. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  303. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  304. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  305. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  306. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  307. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  308. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  309. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  310. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  311. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  312. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  313. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  314. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  315. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  316. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  317. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  318. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  319. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  320. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  321. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  322. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  323. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  324. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  325. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  326. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  327. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  328. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  329. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  330. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  331. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  332. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  333. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  334. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  335. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  336. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  337. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  338. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  339. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  340. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  341. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  342. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  343. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  344. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  345. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  346. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  347. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  348. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  349. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  350. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  351. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  352. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  353. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  354. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  355. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  356. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  357. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  358. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  359. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  360. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  361. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  362. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  363. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  364. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  365. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  366. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  367. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  368. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  369. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  370. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  371. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  372. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  373. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  374. Ma K, et al. 2022. iScience. 25:104347. PubMed
  375. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  376. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  377. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  378. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  379. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  380. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  381. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  382. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  383. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  384. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  385. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  386. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  387. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  388. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  389. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  390. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  391. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  392. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  393. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  394. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  395. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  396. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  397. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  398. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  399. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  400. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  401. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  402. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  403. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  404. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  405. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  406. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  407. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  408. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  409. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  410. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  411. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  412. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  413. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  414. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  415. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  416. Wang X, et al. 2022. Elife. 11:. PubMed
  417. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  418. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  419. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  420. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  421. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  422. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  423. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  424. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  425. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  426. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  427. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  428. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  429. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  430. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07-25-2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL SEK496
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  3. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  4. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  5. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  6. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  7. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  8. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  9. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  10. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  11. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  12. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  13. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  14. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  15. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  16. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  17. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  18. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  19. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  20. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  21. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  22. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  23. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  24. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  25. Chan L, et al. 2022. Cells. 12: . PubMed
  26. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  27. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  28. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  29. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  30. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  31. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  32. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  33. Zander R, et al. 2022. Immunity. 55:475. PubMed
  34. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  35. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  36. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  37. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  38. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  39. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  40. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  41. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  42. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  43. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  44. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  45. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  46. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  47. Wang H, et al. 2023. Nature. 615:339. PubMed
  48. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  49. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  50. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  51. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  52. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  53. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  54. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  55. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  56. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  57. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  58. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  59. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  60. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  61. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  62. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  63. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  64. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  65. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  66. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  67. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  68. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  69. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  70. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  71. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  72. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  73. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  74. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  75. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  76. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  77. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  78. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  79. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  80. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  81. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  82. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  83. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  84. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  85. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  86. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  87. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  88. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  89. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  90. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  91. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  92. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  93. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  94. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  95. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  96. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  97. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  98. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  99. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  100. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  101. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  102. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  103. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  104. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  105. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  106. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  107. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  110. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  111. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  112. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  113. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  114. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  115. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  116. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  117. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  118. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  119. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  120. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  121. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  122. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  123. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  124. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  125. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  126. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  127. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  128. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  129. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  130. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  131. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  132. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  133. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  134. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  135. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  136. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  137. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  138. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  139. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  140. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  141. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  142. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  143. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  144. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  145. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  146. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  147. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  148. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  149. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  150. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  151. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  152. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  153. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  154. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  155. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  156. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  157. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  158. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  159. Ma K, et al. 2022. iScience. 25:104347. PubMed
  160. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  161. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  162. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  163. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  164. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  165. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  166. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  167. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  168. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  169. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  170. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  171. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  172. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  173. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  174. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  175. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  176. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  177. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  178. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  179. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  180. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  181. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  182. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  186. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  187. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  188. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  189. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  190. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  191. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  192. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  193. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  194. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  200. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  201. Wang X, et al. 2022. Elife. 11:. PubMed
  202. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  203. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  204. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  205. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  206. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  207. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  208. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  209. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  210. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  211. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  212. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  213. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  214. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  215. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  216. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  217. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  218. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  219. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  220. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  221. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  222. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  223. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  224. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  225. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  226. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  227. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  228. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  229. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  230. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  231. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  232. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  233. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  234. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  235. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  236. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  237. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  238. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  239. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  240. Chan L, et al. 2022. Cells. 12: . PubMed
  241. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  242. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  243. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  244. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  245. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  246. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  247. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  248. Zander R, et al. 2022. Immunity. 55:475. PubMed
  249. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  250. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  251. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  252. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  253. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  254. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  255. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  256. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  257. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  258. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  259. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  260. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  261. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  262. Wang H, et al. 2023. Nature. 615:339. PubMed
  263. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  264. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  265. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  266. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  267. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  268. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  269. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  270. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  271. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  272. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  273. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  274. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  275. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  276. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  277. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  278. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  279. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  280. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  281. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  282. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  283. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  284. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  285. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  286. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  287. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  288. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  289. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  290. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  291. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  292. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  293. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  294. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  295. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  296. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  297. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  298. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  299. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  300. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  301. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  302. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  303. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  304. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  305. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  306. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  307. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  308. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  309. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  310. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  311. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  312. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  313. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  314. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  315. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  316. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  317. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  318. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  319. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  320. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  321. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  322. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  323. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  324. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  325. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  326. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  327. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  328. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  329. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  330. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  331. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  332. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  333. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  334. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  335. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  336. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  337. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  338. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  339. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  340. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  341. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  342. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  343. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  344. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  345. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  346. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  347. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  348. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  349. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  350. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  351. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  352. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  353. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  354. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  355. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  356. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  357. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  358. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  359. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  360. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  361. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  362. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  363. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  364. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  365. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  366. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  367. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  368. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  369. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  370. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  371. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  372. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  373. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  374. Ma K, et al. 2022. iScience. 25:104347. PubMed
  375. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  376. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  377. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  378. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  379. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  380. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  381. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  382. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  383. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  384. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  385. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  386. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  387. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  388. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  389. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  390. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  391. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  392. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  393. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  394. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  395. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  396. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  397. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  398. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  399. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  400. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  401. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  402. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  403. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  404. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  405. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  406. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  407. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  408. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  409. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  410. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  411. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  412. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  413. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  414. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  415. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  416. Wang X, et al. 2022. Elife. 11:. PubMed
  417. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  418. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  419. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  420. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  421. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  422. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  423. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  424. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  425. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  426. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  427. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  428. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  429. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  430. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07-25-2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account